NRx Pharmaceuticals, Inc. (NRXP) vs Organigram Global Inc. (OGI)
A side-by-side comparison of NRx Pharmaceuticals, Inc. and Organigram Global Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NRXP
NRx Pharmaceuticals, Inc.
$2.90HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
OGI
Organigram Global Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — NRXP vs OGI
growth of $100 · dividends reinvested · last 7yNRXP -97.2% (-40.1%/yr)OGI -97.0% (-39.4%/yr)OGI compounded faster over this window
NRXP OGI
NRXP vs OGI: by the numbers
- •OGI is the larger company ($134M vs $125M market cap).
- •OGI is profitable (27.54% net margin) while NRXP runs a net loss (-691.81%).
Metrics side by side
Valuation
| Metric | NRXP | OGI |
|---|---|---|
| P/E ratio | N/A | 2.13 |
| P/S ratio | 36.93 | 0.60 |
| P/B ratio | N/A | 0.39 |
| EV / EBITDA | N/A | 10.44 |
Profitability
| Metric | NRXP | OGI |
|---|---|---|
| Gross margin | 58.78% | 3.67% |
| Operating margin | -1324.41% | -34.07% |
| Net margin | -691.81% | 27.54% |
| ROE | N/A | 15.55% |
| ROIC | N/A | -0.98% |
Growth (annualized)
| Metric | NRXP | OGI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 29.78% |
| Total return CAGR (5Y) | -49.61% | -36.62% |
Frequently asked
- Is NRXP or OGI more profitable?
- OGI runs the higher net margin — NRXP at -691.81% versus OGI at 27.54%.
- How have NRXP and OGI total returns compared?
- Over the past 5 years, NRXP delivered -49.61% and OGI delivered -36.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Organigram Global P/E ratioNRx Pharmaceuticals ROEOrganigram Global ROENRx Pharmaceuticals operating marginOrganigram Global operating marginNRx Pharmaceuticals revenue growthOrganigram Global revenue growthNRx Pharmaceuticals free cash flowOrganigram Global free cash flow
NRx Pharmaceuticals & Organigram Global appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.